Introduction Non-alcoholic fatty liver disease (NAFLD) is an emerging metabolic disorder around the world, which is featured by excessive hepatic lipid deposition without preexisting liver diseases caused by alcohol abuse ( Recently, natural products play a pivotal role in drug discovery, which also provide new clues to molecular mechanisms of diseases ( in vitro and in vivo ( Dimocarpus longana , Phyllanthus emblica , Phyllanthus reticulatus , and Geranium wilfordii ( in vivo and in vitro by inhibiting Notch signal pathway ( The pathogenesis of NAFLD is complex, and multiple mechanisms may contribute to hepatic lipid deposition ( Materials and methods Animals and treatments Male C57BL/6 mice (four-week-old) were purchased from Beijing SPF experimental animal Technology Co., Ltd
Nature 575, 693698
Products are sold under the "research chemical" or "not for human consumption" designation, which is a legal positioning that carries real risk: no GMP oversight is required, no adverse event reporting is required, and the consumer has no regulatory recourse if a product is mislabeled
That approach improves interpretability, reduces unnecessary escalation, and keeps the work anchored in a research-only context where safety controls and documentation are part of the protocol, not an afterthought
Some individuals might use up their B12 reserves quicker than others, requiring more frequent injections
Whether mitochondrial quality control can restore the function of aggregated lipoylated proteins or other copper-affected enzymes in the pathogenesis of cuproptosis, as some regulatory systems, including the UPS, may be inhibited by copper [147]
